An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: The sirius study

Archives of Internal Medicine

Volumn 160, Issue 22, 2000, Pages 3415-3420

  Samama, Meyer Michel ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBESITY; OUTPATIENT; PLASTER CAST; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; SURGICAL PATIENT; THROMBOEMBOLISM; TRAVEL; VEIN INSUFFICIENCY;

EID: 0034639246     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.22.3415     Document Type: Article

References (37)

1. The venous thrombotic risk in nonsurgical patients
2. Fifth ACCP Consensus Conference on antithrombotic therapy: Prevention of venous thromboembolism
3. Prevention of venous thrornboembolism: European Consensus Statement
4. Incidence of venous thromboembolism verifled by necropsy over 30 years
5. Autopsy proven pulmonary embolism in hospital patients: Are we detecting enough deep vein thrombosis?
6. A reappraisal of the application of the Trendelenburg operation to massive fatal PE: Report of a successful pulmonary-artery thrombectomy using cardiopulmonary bypass
7. Low molecular weight heparin in prevention of perioperative thrombosis
8. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: Overview of results of randomized trials in general, orthopedic, and urologic surgery
9. Prevention of venous thrombosis after general surgery
10. A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery
11. The cost-effectiveness of prevention of post-operative thromboembolism
12. Clinical characteristics of fatal pulmonary embolism in a referral hospital
13. NIH Consensus Development Conference, March 24-26, 1986: Prevention of venous thrombosis and pulmonary embolism
14. Epidemiology of venous thromboembolism
15. The epidemiology of venous thrombosis
16. Characteristics associated with the risk of venous thrombosis
17. A population based perspective of the hospital incidence and case-facility rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study
18. The prevalence of risk factors for venous thromboembolism among hospital patients
19. Smoking and risk factors in deep vein thrombosis
20. A prospective study of the incidence of deep-vein thrombosis within a defined urban population
21. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients
22. Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study
23. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
24. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
25. Physician practices in the management of venous thromboembolism: A community-wide survey
26. Risk factors for pulmonary embolism: The Framingham Study
27. Travel as a risk factor for venous thromboembolic disease: A case-control study
28. Blood groups and blood clotting
29. ABO blood groups and age groups in surgical venous thromboembolism
30. Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias
31. Increased incidence of deep vein thrombosis after myocardial infarction in non-smokers
32. Influence of smoking on deep vein thrombosis after myocardial infarction
33. Preventing thromboembolism after myocardial infarction: Effect of low dose heparin or smoking
34. A prospective study of risk factots for pulmonary embolism in women
35. Smoking and abdominal obesity: Risk factors for venous thrornboembolism among middleaged men: 'The Study of Men Born in 1913.'
36. Venous thromboembolisrn prophylaxis and risk assessment in medical patients
37. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients